Placental Accumulation of Triacylglycerols in Gestational Diabetes Mellitus and Its Association with Altered Fetal Growth are Related to the Differential Expressions of Proteins of Lipid Metabolism

Abstract

Introduction Gestational diabetes mellitus (GDM) exhibit altered placental lipid metabolism. The molecular basis of this altered metabolism is not clear. Altered placental expression of proteins of lipogenesis and fatty acid oxidation may be involved in the placental accumulation of triacylglycerols (TG). The present study was aimed at investigating the differential expressions of placental proteins related to lipid metabolism among GDM women in comparison with control pregnant women (CPW) and to correlate them with maternal and fetal lipid parameters as well as altered fetal growth.

Materials and Methods Maternal blood, cord blood, and placental samples were collected from GDM and CPW. The biochemical parameters, glucose, lipid profile and free fatty acids (FFA) were measured. The placental TG content was measured. Differential placental expressions of proteins; phosphatidylinositol-3-kinase (PI3K) p85α, PI3K p110α,liver X receptor alpha (LXRα), sterol regulatory element binding protein1(SREBP1), fatty acid synthase (FAS), stearyl CoA desaturase1 (SCD1), lipoprotein lipase (LPL),Peroxisome proliferator-activated receptor (PPAR)α and PPARγ were analysed by western blotting and immunohistochemistry.

Results Placental protein expressions of PI3K p110α, LXRα, FAS, SCD1, and LPL were found to be significantly higher, whereas PPARα and PPARγ were lower in GDM women compared with CPW. The placental TG content and cord plasma FFA were increased in GDM women compared with CPW. The placental TG content positively correlated with Ponderal index of GDM new-borns.

Conclusion Differential expressions of placental proteins related to lipid metabolism in GDM might have led to placental TG accumulation. This might have contributed to the fetal overgrowth in GDM.

Key words

gestational diabetes mellitus - lipogenesis - fatty acid oxidation - placental triacylglycerols - free fatty acids - fetal adiposity

Publication History

Received: 13 May 2019
Received: 09 September 2019

Accepted: 23 September 2019

Article published online:
22 January 2020

• References

• 1 Mitanchez D. Fetal and neonatal complications of gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal outcomes. J Gynecol Obstet Biol Reprod [Paris] 2010; 39: S189-S199
• 2 Yessoufou A, Moutairou K. Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of “metabolic memory.”. Exp Diabetes Res 2011; 218598
• 3 HAPO Study Cooperative Research Group Hyperglycemia and Adverse Pregnancy Outcome [HAPO] Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453-459
• 4 Dabelea D, Crume T. Maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 2011; 60: 1849-1855
• 5 Fraser D, Weitzman S, Leiberman JR. et al. Factors influencing birth weight in newborns of diabetic and non-diabetic women. A population based study. Eur J Epidemiol 1990; 6: 427-431
• 6 Schwartz R, Gruppuso PA, Petzold K. et al. Hyperinsulinemia and macrosomia in the fetus of the diabetic mother. Diabetes Care 1994; 17: 640-648
• 7 Szabo AJ, Szabo O. Placental free-fatty-acid transfer and fetal adipose-tissue development: an explantation of fetal adiposity in infants of diabetic mothers. Lancet Lond Engl 1974; 2: 498-499
• 8 Kitajima M, Oka S, Yasuhi I. et al. Maternal serum triglyceride at 24--32 weeks’ gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol 2001; 97: 776-780
• 9 Schaefer-Graf UM, Graf K, Kulbacka I. et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 2008; 31: 1858-1863
• 10 Metzger BE, Phelps RL, Freinkel N. et al. Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. Diabetes Care 1980; 3: 402-409
• 11 Montelongo A, Lasunción MA, Pallardo LF. et al. Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes 1992; 41: 1651-1659
• 12 Herrera E. Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development–a review. Placenta 2002; 23: S9-S19
• 13 Shafrir E, Khassis S. Maternal-fetal fat transport versus new fat synthesis in the pregnant diabetic rat. Diabetologia 1982; 22: 111-117
• 14 Diamant YZ, Metzger BE, Freinkel N. et al. Placental lipid and glycogen content in human and experimental diabetes mellitus. Am J Obstet Gynecol 1982; 144: 5-11
• 15 Hao J, Liu S, Zhao S. et al. PI3K/Akt pathway mediates high glucose-induced lipogenesis and extracellular matrix accumulation in HKC cells through regulation of SREBP-1 and TGF-β1. Histochem Cell Biol 2011; 135: 173-181
• 16 Soliman GA. The integral role of mTOR in lipid metabolism. Cell Cycle 2011; 10: 861-862
• 17 Joseph SB, Laffitte BA, Patel PH. et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 2002; 277: 11019-11025
• 18 Li J, Luo J, Zhu J. et al. Regulation of the fatty acid synthase promoter by liver X receptor α through direct and indirect mechanisms in goat mammary epithelial cells. Comp Biochem Physiol B Biochem Mol Biol 2015; 184: 44-51
• 19 Chu K, Miyazaki M, Man WC. et al. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation. Mol Cell Biol 2006; 26: 6786-6798
• 20 International Association of Diabetes and Pregnancy Study Groups Consensus Panel . Metzger BE, Gabbe SG. et al. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33: 676-682
• 21 Trebotic LK, Klimek P, Thomas A. et al. Circulating betatrophin is strongly increased in pregnancy and gestational diabetes mellitus. PloS One. 2015; 10: e0136701
• 22 Colomiere M, Permezel M, Riley C. et al. Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol 2009; 160: 567-578
• 23 Lappas M, Permezel M, Holdsworth SJ. et al. Antiinflammatory effects of the cyclopentenone isoprostane 15-A[2]-IsoP in human gestational tissues. Free Radic Biol Med 2007; 15: 1791-1796
• 24 Visiedo F, Bugatto F, Sánchez V. et al. High glucose levels reduce fatty acid oxidation and increase triglyceride accumulation in human placenta. Am J Physiol Endocrinol Metab 2013; 15: E205-E212
• 25 Herrera E, Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy - Are these the cause of the problem. Best Pract Res Clin Endocrinol Metab 2010; 24: 515-525
• 26 Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H. et al. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med J Br Diabet Assoc 2011; 28: 1053-1059
• 27 Herrera E, Desoye G. Maternal and fetal lipid metabolism under normal and gestational diabetic conditions. Horm Mol Biol Clin Investig 2016; 1: 109-127
• 28 Couch SC, Philipson EH, Bendel RB. et al. Elevated lipoprotein lipids and gestational hormones in women with diet-treated gestational diabetes mellitus compared to healthy pregnant controls. J Diabetes Complications 1998; 12: 1-9
• 29 Bartha JL, Comino-Delgado R, Martinez-Del-Fresno P. et al. Insulin-sensitivity index and carbohydrate and lipid metabolism in gestational diabetes. J Reprod Med 2000; 45: 185-189
• 30 Sobki SH, Al-Senaidy AM, Al-Shammari TA. et al. Impact of gestational diabetes on lipid profiling and indices of oxidative stress in maternal and cord plasma. Saudi Med J 2004; 25: 876-880
• 31 Couch SC, Philipson EH, Bendel RB. et al. Maternal and cord plasma lipid and lipoprotein concentrations in women with and without gestational diabetes mellitus. Predictors of birth weight?. J Reprod Med 1998; 43: 816-822
• 32 Kautzky-Willer A, Krssak M, Winzer C. et al. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 2003; 52: 244-251
• 33 Radaelli T, Lepercq J, Varastehpour A. et al. Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Am J Obstet Gynecol 2009; 201: 209.e1-209.e10
• 34 Radaelli T, Varastehpour A, Catalano P. et al. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003; 52: 2951-2958
• 35 Fresno Vara JA, Casado E, de Castro J. et al. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 2004; 30: 193-204
• 36 Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis Int J Program Cell Death. 2004; 9 667-676
• 37 Fingar DC, Richardson CJ, Tee AR. et al. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 2004; 24: 200-216
• 38 Ruiz-Palacios M, Prieto-Sánchez MT, Ruiz-Alcaraz AJ. et al. Insulin treatment may alter fatty acid carriers in placentas from gestational diabetes subjects. Int J Mol Sci 2017; 6: 18
• 39 Ruiz-Palacios M, Ruiz-Alcaraz AJ, Sanchez-Campillo M. et al. Role of insulin in placental transport of nutrients in gestational diabetes mellitus. Ann Nutr Metab 2017; 70: 16-25
• 40 Yadav UCS, Ramana KV. Regulation of NF-κB-induced inflammatory signaling by lipid peroxidation-derived aldehydes. Oxid Med Cell Longev 2013; 2013: 690545
• 41 Manoharan B, Bobby Z, Dorairajan G. et al. Increased placental expressions of nuclear factor erythroid 2-related factor 2 and antioxidant enzymes in gestational diabetes: Protective mechanisms against the placental oxidative stress?. Eur J Obstet Gynecol Reprod Biol 2019; 238: 78-85
• 42 Jeon T-I, Osborne TF. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab TEM 2012; 23: 65-72
• 43 Krycer JR, Sharpe LJ, Luu W. et al. The Akt-SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol Metab TEM 2010; 21: 268-276
• 44 Sipula IJ, Brown NF, Perdomo G. Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation. Metabolism 2006; 55: 1637-1644
• 45 Liu DD, Han CC, Wan HF. et al. Effects of inhibiting PI3K-Akt-mTOR pathway on lipid metabolism homeostasis in goose primary hepatocytes. Anim Int J Anim Biosci. 2016; 10 1319-1327
• 46 Sul HS, Wang D. Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu Rev Nutr 1998; 18: 331-351
• 47 Marseille-Tremblay C, Ethier-Chiasson M, Forest J-C. et al. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Mol Reprod Dev 2008; 75: 1054-1062
• 48 Sampath H, Miyazaki M, Dobrzyn A. et al. Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. J Biol Chem 2007; 26: 2483-2493
• 49 Chong MF-F, Hodson L, Bickerton AS. et al. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding. Am J Clin Nutr 2008; 87: 817-823
• 50 Rakhshandehroo M, Knoch B, Müller M. et al. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res 2010;
• 51 Janani C, Ranjitha Kumari BD. PPAR gamma gene--a review. Diabetes Metab Syndr. 2015; 1: 46-50
• 52 Holdsworth-Carson SJ, Lim R, Mitton A. et al. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta 2010; 31: 222-229
• 53 Dubé E, Ethier-Chiasson M, Lafond J. Modulation of cholesterol transport by insulin-treated gestational diabetes mellitus in human full-term placenta. Biol Reprod 2013; 88: 16
• 54 Gauster M, Hiden U, Blaschitz A. et al. Dysregulation of placental endothelial lipase and lipoprotein lipase in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab 2007; 92: 2256-2263
• 55 Zhang Y, Repa JJ, Gauthier K. et al. Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta. J Biol Chem 2001; 16: 276 43018–43024
• 56 Lindegaard MLS, Damm P, Mathiesen ER. et al. Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression. J Lipid Res 2006; 47: 2581-2588
• 57 Magnusson-Olsson AL, Hamark B, Ericsson A. et al. Gestational and hormonal regulation of human placental lipoprotein lipase. J Lipid Res 2006; 47: 2551-2561
• 58 Kersten S, Mandard S, Tan NS. et al. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 2000; 275: 28488-28493
• 59 Shan L, Yu X-C, Liu Z. et al. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J Biol Chem 2009; 284: 1419-1424
• 60 Manoharan B, Bobby Z, Dorairajan G. et al. Adipokine levels and their association with insulin resistance and fetal outcomes among the newborns of Indian gestational diabetic mothers. Saudi Med J 2019; 40: 353-359